PMI
Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the USA, Europe, and internationally. The company was incorporated in 2021 and is based in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.10 | $1M | -$4M |
| 2025 Q4 | -0.06 | $1M | -$4M |
| 2025 Q3 | -0.19 | $1M | -$7M |
| 2025 Q2 | -0.10 | $2M | -$3M |
| 2025 Q1 | -0.09 | $620,000 | -$2M |
| 2024 Q4 | -0.13 | $836,000 | -$3M |
| 2024 Q3 | -0.10 | $881,000 | -$3M |
| 2024 Q2 | -0.07 | $694,000 |
| -$4M |